AR075158A1 - Derivados de pirrolopirimidinas, composiciones farmaceuticas y usos. - Google Patents
Derivados de pirrolopirimidinas, composiciones farmaceuticas y usos.Info
- Publication number
- AR075158A1 AR075158A1 ARP100100158A ARP100100158A AR075158A1 AR 075158 A1 AR075158 A1 AR 075158A1 AR P100100158 A ARP100100158 A AR P100100158A AR P100100158 A ARP100100158 A AR P100100158A AR 075158 A1 AR075158 A1 AR 075158A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- hydrogen atom
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuesto en el cual los símbolos son como se los describio en la memoria descriptiva o una de sus sales, que es util para prevenir/tratar enfermedades asociadas con eicosanoides tales como ateroesclerosis, diabetes, obesidad, aterotrombosis, asma, fiebre, dolor, cáncer, reumatismo, osteoartritis y dermatitis atopica, y que tiene una excelente accion farmacologica, propiedades fisicoquímicas, etc. Reivindicacion 1: Un compuesto representado caracterizado por la formula (1) en la cual R1 es un átomo de hidrogeno, un alquilo C1-6 sustituido o no sustituido, un cicloalquilo C3-8 sustituido o no sustituido, un amino sustituido o no sustituido, -OR', -SR', -SOR'' o -SO2Rö en la cual R' es un átomo de hidrogeno, un alquilo C1-6 sustituido o no sustituido, un cicloalquilo C3-6 sustituido o no sustituido, o un grupo cíclico sustituido o no sustituido; y Rö es un alquilo C1-6 sustituido o no sustituido, un cicloalquilo C3-6 sustituido o no sustituido, o un grupo cíclico sustituido o no sustituido; R2 es un átomo de hidrogeno, un átomo de halogeno, un alquilo C1-6 sustituido o no sustituido, o un alcoxi C1-6 sustituido o no sustituido; n es un numero entero desde 1 hasta 5; un anillo condensado que incluye el Arcillo A es un anillo representado por cualquiera de las formulas (2); en la cual R3es un átomo de hidrogeno, un alquilo C1-6 sustituido o no sustituido, o un cicloalquilo C3-8 sustituido o no sustituido; R4 es un átomo de hidrogeno, un átomo de halogeno, un hidroxi, un alquilo C1-6 sustituido o no sustituido, o un alcoxi C1-6 sustituido o no sustituido; R5 es un átomo de hidrogeno, o un alquilo C1-6 sustituido o no sustituido; R6 es un átomo de hidrogeno, un alquilo C1-6 sustituido o no sustituido, o un cicloalquilo C3-8 sustituido o no sustituido; R7 es un átomo de hidrogeno, un átomo de halogeno, un hidroxi sustituido o no sustituido, un alquilo C2-6, un alquilo C1-6 sustituido, o un alcoxi C1-6 sustituido o no sustituido; y R8 es un átomo de hidrogeno o un átomo do halogeno; y el Anillo B es un anillo de 5 o 6 miembros, con la condicion que, cuando R4 es un átomo de hidrogeno, un átomo de halogeno, un alquilo C1-6 sustituido o no sustituido o un alcoxi C1-6 sustituido o no sustituido, o cuando R7 es un átomo de hidrogeno, un átomo de halogeno, un hidroxi sustituido, un alquilo C2-6, un alquilo C1-6 sustituido o un alcoxi C1-6 sustituido o no sustituido, el Anillo B es un anillo representado por la formula (3) en la cual R2' es un alquilo C1-6 sustituido o no sustituido o un alcoxi C1-6 sustituido o no sustituido; y Ra es un átomo de hidrogeno, un átomo de halogeno, un alquilo C1-6 sustituido o no sustituido, o un alcoxi C1-6 sustituido o no sustituido, o una de sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009015832 | 2009-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR075158A1 true AR075158A1 (es) | 2011-03-16 |
Family
ID=42027846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100100158A AR075158A1 (es) | 2009-01-27 | 2010-01-26 | Derivados de pirrolopirimidinas, composiciones farmaceuticas y usos. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100190747A1 (es) |
| EP (1) | EP2382218A1 (es) |
| JP (1) | JP2012516321A (es) |
| AR (1) | AR075158A1 (es) |
| TW (1) | TW201033213A (es) |
| UY (1) | UY32395A (es) |
| WO (1) | WO2010087467A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011047319A2 (en) | 2009-10-16 | 2011-04-21 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
| EA023350B1 (ru) | 2009-10-16 | 2016-05-31 | Мелинта Терапьютикс, Инк. | Противомикробные соединения, способы их получения и применение |
| EP3421476A1 (en) | 2009-10-16 | 2019-01-02 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| CN103119043A (zh) | 2010-07-23 | 2013-05-22 | 武田药品工业株式会社 | 稠合的杂环化合物及其用途 |
| WO2012011592A1 (ja) * | 2010-07-23 | 2012-01-26 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| JP6317669B2 (ja) | 2011-04-15 | 2018-04-25 | メリンタ セラピューティクス インコーポレイテッド | 抗菌化合物ならびにそれを作製および使用する方法 |
| EP2935267A1 (de) * | 2012-12-20 | 2015-10-28 | Bayer CropScience AG | Arylsulfid- und arylsulfoxid-derivate als akarizide und insektizide |
| MX2016003046A (es) | 2013-09-09 | 2016-09-08 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. |
| WO2015035426A1 (en) | 2013-09-09 | 2015-03-12 | Melinta Therapeutics, Inc. | Antimicrobial compunds and methods of making and using the same |
| WO2016132355A1 (en) * | 2015-02-16 | 2016-08-25 | B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Introduction of alkyl substituents to aromatic compounds |
| HK1249758A1 (zh) | 2015-03-11 | 2018-11-09 | Melinta Therapeutics, Inc. | 抗微生物化合物及其制备和使用方法 |
| US11098047B2 (en) | 2016-05-06 | 2021-08-24 | BioVersys AG | Antimicrobials and methods of making and using same |
| US10639313B2 (en) | 2017-09-01 | 2020-05-05 | Ndsu Research Foundation | Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation |
| CN114728167B (zh) | 2019-11-25 | 2024-03-19 | 安进公司 | 作为δ-5脱饱和酶抑制剂的杂环化合物以及使用方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
| US6057338A (en) | 1997-04-04 | 2000-05-02 | Merck & Co., Inc. | Somatostatin agonists |
| AU1285499A (en) | 1997-10-30 | 1999-05-24 | Merck & Co., Inc. | Somatostatin agonists |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| EP1227090A4 (en) | 1999-10-07 | 2002-11-20 | Tadeka Chemical Ind Ltd | AMINE DERIVATIVES |
| PL360398A1 (en) | 2000-07-13 | 2004-09-06 | Takeda Chemical Industries, Ltd. | Lipid-rich plaque inhibitors |
| EP1302462A4 (en) | 2000-07-17 | 2007-07-18 | Takeda Pharmaceutical | SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF |
| US20050245571A1 (en) | 2001-10-19 | 2005-11-03 | Hidenori Abe | Amine derivative |
| NZ533893A (en) | 2002-01-11 | 2006-06-30 | Takeda Pharmaceutical | Coumarin derivatives, process for their production and use thereof |
| CN1310918C (zh) | 2002-09-04 | 2007-04-18 | 先灵公司 | 作为细胞周期蛋白依赖激酶抑制剂的吡唑并嘧啶 |
| CA2507026A1 (en) | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, their production and use |
| EP1669352A4 (en) | 2003-09-30 | 2008-12-17 | Takeda Pharmaceutical | THIAZOLINE DERIVATIVE AND ITS USE |
| AU2004290626A1 (en) * | 2003-11-14 | 2005-06-02 | Merck Sharp & Dohme Limited | Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) |
| CA2550012A1 (en) | 2003-12-17 | 2005-06-30 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same and use |
| MXPA06012323A (es) | 2004-04-28 | 2007-01-17 | Takeda Pharmaceutical | Derivado de quinolina fusionada y uso del mismo. |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| ATE474829T1 (de) | 2005-06-27 | 2010-08-15 | Amgen Inc | Entzündungshemmende arylnitrilverbindungen |
| PT2248812E (pt) | 2006-06-27 | 2014-03-12 | Takeda Pharmaceutical | Compostos cíclicos fundidos como moduladores do receptor gpr40 |
| US20080194557A1 (en) | 2007-01-18 | 2008-08-14 | Joseph Barbosa | Methods and compositions for the treatment of pain, inflammation and cancer |
| US20080200458A1 (en) | 2007-01-18 | 2008-08-21 | Joseph Barbosa | Methods and compositions for the treatment of body composition disorders |
-
2010
- 2010-01-26 US US12/656,332 patent/US20100190747A1/en not_active Abandoned
- 2010-01-26 JP JP2011547343A patent/JP2012516321A/ja not_active Withdrawn
- 2010-01-26 UY UY0001032395A patent/UY32395A/es not_active Application Discontinuation
- 2010-01-26 TW TW099102036A patent/TW201033213A/zh unknown
- 2010-01-26 EP EP10702931A patent/EP2382218A1/en not_active Withdrawn
- 2010-01-26 WO PCT/JP2010/051307 patent/WO2010087467A1/en not_active Ceased
- 2010-01-26 AR ARP100100158A patent/AR075158A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201033213A (en) | 2010-09-16 |
| US20100190747A1 (en) | 2010-07-29 |
| EP2382218A1 (en) | 2011-11-02 |
| JP2012516321A (ja) | 2012-07-19 |
| UY32395A (es) | 2010-08-31 |
| WO2010087467A1 (en) | 2010-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR075158A1 (es) | Derivados de pirrolopirimidinas, composiciones farmaceuticas y usos. | |
| PE20160661A1 (es) | Compuesto de azapiridona y sus usos de los mismos | |
| ECSP16025201A (es) | Profármacos de amidas de piridona útiles como moduladores de canales de sodio | |
| ECSP11010804A (es) | Compuestos orgánicos | |
| CY1120682T1 (el) | Ενωσεις για την προστασια κυτταρων | |
| UY30804A1 (es) | Derivados de nicotinamida, sus sales y solvatos, composiciones farmacéuticas conteniendolas y aplicaciones | |
| MX2018005890A (es) | Composiciones para tratar atrofia muscular espinal. | |
| CY1119015T1 (el) | 4'-αζιδο-3'φθορο υποκατεστημενα νουκλεοζιδιου παραγωγα ως αναστολεις αντιγραφης hcv rna | |
| BR112017006305A2 (pt) | compostos heteroarila como inibidores de btk e usos dos mesmos | |
| MX376271B (es) | Compuestos heterocíclicos y usos de los mismos. | |
| CO7400867A2 (es) | Modificador del sabor dulce | |
| CL2015001304A1 (es) | Compuestos derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina; composicion farmaceutica; combinacion farmaceutica; y metodo para la preparacion de compuestos. | |
| BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
| CR20160119A (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística | |
| CR20160296A (es) | Benzamidas sustituidas y métodos para usarlas | |
| ECSP11011470A (es) | Nuevos derivados de pirimidina y sus usos en el tratamiento del cáncer y otras enfermedades | |
| ECSP13012958A (es) | Inhibidores de benzodioxano de la producción de leucotrieno. | |
| CO7111275A2 (es) | Inhibidores de dgat1 de éter cíclico de cabeza de puente | |
| BR112017005917A2 (pt) | processos e composições para indução de imunidade protetora contra infecção com o vírus da imunodeficiência humana | |
| UY37378A (es) | Compuestos tricíclicos fusionados de piridazinona útiles para tratar infecciones de orthomyxovirus | |
| UY30938A1 (es) | Derivados de nicotinamida, sales y solvatos farmacéuticamente aceptables, composiciones y aplicaciones. | |
| EA201200471A1 (ru) | Простые эфирные производные бициклических гетероарилов | |
| NI201000039A (es) | Derivados de quinazolinadiona, su preparación y sus aplicaciones terapéuticas. | |
| CL2015001319A1 (es) | Compuestos derivados de n-(piridin-2-il)pirimidin-4-amina que contienen un grupo sulfoximina; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y metodo para la preparacion de compuestos. | |
| CR20140078A (es) | Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |